Deals between biopharma companies and government or nonprofit entities, including: Actinium, Angiogenex, Axovant, Bellicum, Bicycle, Canonic, Celgene, Chongqing Zhifei, Cytovia, Decibel, Dinaqor, Diomics, Eagle, Ervaxx, G1, Gene Techno, Genentech, Genethon, Gilead, GSK, Horizon, Hoth, Medigene, Microcures, Moderna, Novartis, Oncotartis, Onxeo, Opiant, Orion, Sapphire, Tacitus, Titan, Valneva, Yposkesi, Zyus.